DG

DANIEL GRAVER

AKIN GUMP STRAUSS HAUER & FELD · WASHINGTON, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

3

last 3 years

Filings

10

4 agencies contacted

Activity

filings by quarter

Works on

Health Issues 8 Manufacturing 5 Pharmacy 4 Defense 2

Background

Government experience

Leg asst

Rep Giffords, 2007-08; leg aide, Rep Grijalva, 2005.

Disclosed on LD-2 filings

Leg asst

Rep Giffords, 2007-08; leg aide, Rep Grijalva, 2005

Disclosed on LD-2 filings

Career

AG

AKIN GUMP STRAUSS HAUER & FELD

WASHINGTON, DC

2024 - present

Specific issues

Issues related to strengthening and securing U.S. pharmaceutical manufacturing supply chains in S.4638 - National Defense Authorization Act for Fiscal Year 2025 and H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; H.R.10545 - American Relief Act, 2025 (PL 118-158).

Health Issues · 2024 Q4

Issues related to electronic provider payments; H.R.6487/S.3805 - No Fees for EFTs Act.

Health Issues · 2024 Q4

Issues related to health care supply chain and domestic pharmaceutical manufacturing; H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S.4638 - National Defense Authorization Act for Fiscal Year 2025.

Defense · 2024 Q4

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Manufacturing · 2024 Q4

Issues related to strengthening and securing U.S. pharmaceutical manufacturing supply chains in S.4638 - National Defense Authorization Act for Fiscal Year 2025 and H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025.

Manufacturing · 2024 Q3

Issues related to electronic provider payments.

Health Issues · 2024 Q2